Navigationshilfe

Hauptnavigation

Seiteninhalt

Publikationen

2014   2013   2012   2011   2010   2009   2008   2007

     2006   2005   2004   2003   2002   2001   2000

2012

Originalarbeiten | Original Articles

  1. Alves G*, Karakaya T*, Fußer F*, Kordulla M, O’Dwyer L, Christl J, Magerkurth J, Oertel-Knöchel V, Knöchel C, Prvulovic D, Jurcoane A, Laks J, Engelhardt E, Hampel H, Pantel J. Association of microstructural white matter abnormalities with cognitive dysfunction in geriatric patients with major depression. Psychiatry Res: Neuroimaging. 2012; 203(2-3):194-200. Epub 2012 Sep 6. (*equal contribution)

  2. Alves GS, O’Dwyer L, Jurcoane A, Oertel-Knöchel V, Knöchel C, Prvulovic D, Sudo F, Alves CE, Valente L, Moreira D, Fußer F, Karakaya T, Pantel J, Engelhardt E, Laks J. Different patterns of white matter degeneration using multipleCdiffusion indices and volumetric data in mild cognitive impairment and Alzheimer patients. PLoS One. 2012; 7(12):e52859. Epub 2012 Dec 31.

  3. Bartley M, Bokde AL, Ewers M, Faluyi YO, Tobin WO, Snow A, Connolly J, Delaney C, Coughlan T, Collins DR, Hampel H, O’Neill D. Subjective memory complaints in community dwelling healthy older people: the influence of brain and psychopathology. Int J Geriatr Psychiatry. 2012; 27(8):836-43. Epub 2011 Sep 27.

  4. Bölte S, Schlitt S, Gapp V, Hainz D, Schirman S, Poustka F, Weber B, Freitag C, Ciaramidaro A, Walter H. A close eye on the eagle-eyed visual acuity hypothesis of autism. J Autism Dev Disord. 2012; 42(5):726-33.

  5. Buschert VC, Giegling I, Teipel SJ, Jolk S, Hampel H, Rujescu D, Buerger K. Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment. J Clin Psychiat. 2012; 73(12):e1492-8.

  6. Conner KR, Beautrais AL, Brent DA, Conwell Y, Phillips MR, Schneider B. The next generation of psychological autopsy studies: Part 2. Interview procedures. Suicide Life-Threat. 2012; 42(1):86-103. Epub 2012 Jan 30.

  7. Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V, Hampel H, Kastler J, Senn H. Metabolite profiling of Alzheimer’s disease cerebrospinal fluid. PLoS One. 2012. 7(2):e31501. Epub 2012 Feb 16.

  8. Engelbach U, Herpertz S. Teufelskreis: Depression und Diabetes mellitus. ÄP Neurologie, Psychiatrie. 2012; H. 3:23-25.

  9. Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, Minthun L, Trojanowski JQ, Shaw LM, Faluyi YO, Vellas B, Dubois B, Blennow K, Buerger K, Teipel SJ, Weiner M, Hampel H. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer’s disease. Neurobiol Aging. 2012; 33(8):1599-608. Epub 2011 Jun 17.

  10. Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR Jr, Feldman HH, Bokde AL, Alexander GE, Scheltens P, Vellas B, Dubois B, Weiner M, Hampel H; North American Alzheimer’s Disease Neuroimaging Initiative (ADNI). Prediction of conversion from mild cognitive impairment to Alzheimer’s disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging. 2012; 33(7):1203-14.e2. Epub 2010 Dec 14.

  11. Fehlbaum-Beurdeley P, Sol O, Désiré L, Touchon J, Dantoine T, Vercelletto M, Gabelle A, Jarrige AC, Haddad R, Lemarié JC, Zhou W, Hampel H, Einstein R, Vellas B, EHTAD/002 study group. Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimers disease. J Alzheimers Dis. 2012; 32(1):169-81.

  12. Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Kölsch H, Heun R, Schürmann B, Bussche HV, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Davies G, Harris SE, Starr JM, Deary IJ, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Jones L, Holmans PA, O’Donovan MC, Owen MJ, Williams J. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer’s disease. J Alzheimers Dis. 2012; 28(2):377-87. Epub 2011 Oct 25.

  13. Hampel H, Lista S. Alzheimer disease: From inherited to sporadic AD-crossing the biomarker bridge. Nat Rev Neurol. 2012; 8(11):598-600. Epub 2012 Sep 25.

  14. Hampel H, Prvulovic D. Are biomarkers harmful to recruitment and retention in Alzheimer’s disease clinical trials? An international perspective. J Nutr Health Aging. 2012; 16(4):346-8.

  15. Hoffstaedter F, Sarlon J, Grefkes C, Eickhoff SB. Internally vs. externally triggered movements in patients with major depression. Behav Brain Res. 2012; 228(1):125-32. Epub 2011 Nov 28.

  16. Hummel D, Grabhorn R, Mohr HM. Body-shape adaptation cannot be explained by adaptation to narrow and wide rectangles. Perception. 2012;41(11):1315-22.

  17. Hummel D, Rudolf AK, Untch KH, Grabhorn R, Mohr HM. Visual adaptation to thin and fat bodies transfers across identity. PLoS One. 2012; 7(8):e43195.

  18. Jacobs HI, Visser PJ, Van Boxtel MP, Frisoni GB, Tsolaki M, Papapostolou P, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, van de Pol L, Scheltens P, Tan FE, Jolles J, Verhey FR. Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging. 2012; 33(1):201.e1-8. Epub 2010 Aug 23.

  19. Klingberg S, Herrlich J, Wiedemann G, Wölwer W, Meisner C, Engel C, Jakobi-Malterre UE, Buchkremer G, Wittorf A. Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study. J Nerv Ment Dis. 2012; 200(7):569-76.

  20. Knöchel C, O’Dwyer L, Alves G, Reinke B, Magerkurth J, Rotarska-Jagiela A, Prvulovic D, Hampel H, Linden DE, Oertel-Knöchel V. Association between white matter fiber integrity and subclinical psychotic symptoms in schizophrenia patients and unaffected relatives. Schizophr Res. 2012 Sep;140(1-3):129-35. Epub 2012 Jul 19.

  21. Knöchel C, Oertel-Knöchel V, Schönmeyer R, Rotarska-Jagiela A, van de Ven V, Prvulovic D, Haenschel C, Uhlhaas P, Pantel J, Hampel H, Linden DE. Interhemispheric hypoconnectivity in schizophrenia: fiber integrity and volume differences of the corpus callosum in patients and unaffected relatives. Neuroimage. 2012; 59(2):926-34. Epub 2011 Sep 26.

  22. Koch W, Teipel S, Mueller S, Benninghoff J, Wagner M, Bokde ALW, Hampel H, Coates U, Reiser M, Meindl T. Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer’s disease. Neurobiol Aging. 2012; 33(3):466-78. Epub 2010 Jun 10.

  23. Leuner K, Schulz K, Schütt T, Pantel J, Prvulovic D, Rhein V, Savaskan E, Czech C, Eckert A, Müller WE. Peripheral mitochondrial dysfunction in Alzheimers disease: focus on lymphocytes. Mol Neurobiol. 2012; 46(1):194-204. Epub 2012 Jul 22.

  24. Likitjaroen Y, Meindl T, Friese, U, Wagner M, Buerger K, Hampel H, Teipel SJ. Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month ranomized, placebo-controlled, double-blinded study. Eur Arch Psychiatry Clin Neurosci. 2012; 262(4):341-50. Epub 2011 Aug 5.

  25. Mattsson N, Rosén E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek MM, Olde Rikkert M, Tsolaki M, Mulugeta E, Aarsland D, Visser PJ, Schroeder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Wallin A, Eriksdotter-Jönhagen M, Minthon L, Winblad B, Blennow K, Zetterberg H. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology. 2012; 78(7):468-76. Epub 2012 Feb 1.

  26. Matura S, Muth K, Magerkurth J, Walter H, Klein J, Haenschel C, Pantel J. Neural correlates of autobiographical memory in amnestic Mild Cognitive Impairment. Psychiatry Res: Neuroimaging, 2012; 201(2):159-67. Epub 2012 Mar 14.

  27. O’Dwyer L, Lamberton F, Bokde AL, Ewers M, Faluyi YO. Tanner C, Mazoyer B, O’Neill D, Bartley M, Collins DR, Coughlan T, Prvulovic D, Hampel H. Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment. PloS One. 2012; 7(2):e32441. Epub 2012 Feb 23.

  28. O’Dwyer L, Lamberton F, Bokde AL, Ewers M, Faluyi YO, Tanner C, Mazoyer B, O’Neill D, Bartley M, Collins R, Coughlan T, Prvulovic D, Hampel H. Sexual dimorphism in healthy aging and mild cognitive impairment: A DTI Study. PLoS One. 2012; 7(7):e37021. Epub 2012 Jul 2.

  29. O’Dwyer L, Lamberton F, Matura S, Scheibe M, Miller J, Rujescu D, Prvulovic D, Hampel H. White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines. PLoS One. 2012; 7(4):e36024. Epub 2012 Apr 25.

  30. ODwyer L, Lamberton F, Matura S, Tanner C, Scheibe M, Miller J, Rujescu D, Prvulovic D, Hampel H. Reduced hippocampal volume in healthy young ApoE4 carriers: an MRI study. PloS One. 2012; 7(11):e48895.

  31. Oertel-Knöchel V, Knöchel C, Matura S, Rotarska-Jagiela A, Magerkurth J, Prvulovic D, Haenschel C, Hampel H, Linden DE. Cortical-basal ganglia imbalance in schizophrenia patients and unaffected first-degree relatives. Schizophr Res. 2012; 138(2-3):120-7. Epub 2012 Mar 29.

  32. Oertel-Knöchel V, Knöchel C, Stäblein M, Linden DE. Abnormal functional and structural asymmetry as biomarker for schizophrenia. Curr Top Med Chem. 2012; 12(21):2434-51.

  33. Oertel-Knöchel V, Reinke B, Hornung A, Knöchel C, Matura S, Knopf M, Prvulovic D, O’Dwyer L, Lindner M, Rau A, Hampel H, Haenschel C, Linden DE. Patterns of autobiographical memory in bipolar disorder examined by psychometric and functional neuroimaging methods. J Nerv Ment Dis. 2012; 200(4):296-304.

  34. Roggendorf J, Chen S, Baudrexel S, van de Loo S, Seifried C, Hilker R. Arm swing asymmetry in Parkinson’s disease measured with ultrasound based motion analysis during treadmill gait. Gait Posture. 2012; 35(1):116-20. Epub 2011 Sep 29.

  35. Roux F, Wibral M, Mohr HM, Singer W, Uhlhaas PJ. Gamma-band activity in human prefrontal cortex codes for the number of relevant items maintained in working memory. J Neurosci. 2012;32(36):12411-20.

  36. Santos AN, Ewers M, Minthon L, Simm A, Silber RE, Blennow K, Prvulovic D, Hansson O, Hampel H. Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer’s Disease. J Alzheimers Dis. 2012; 29(1):171-6. Epub 2012 Jan 3.

  37. Schneider B. Behavioural therapy of suicidality. Eur Arch Psy Clin N. 2012; 262(Suppl 2):S123-8. Epub 2012 Aug 28.

  38. Seifried C, Weise L, Hartmann R, Gasser T, Baudrexel S, Szelényi A, van de Loo S, Steinmetz H, Seifert V, Roeper J, Hilker R. Intraoperative microelectrode recording for the delineation of subthalamic nucleus topography in Parkinsons disease. Brain Stimul. 2012; 5(3):378-87. Epub 2011 Jul 8.

  39. Soldner J, Meindl T, Koch W, Bokde ALW, Reiser MF, Möller HJ, Bürger K, Hampel H, Teipel SJ. Strukturelle und funktionelle neuronale Konnektivität bei der Alzheimer-Krankheit. Eine kombinierte DTI- und fMRT-Studie. [Structural and functional neuronal connectivity in Alzheimer’s disease: A combined DTI and fMRI study.] Nervenarzt. 2012; 83(7):878-87. Epub 2011 Jun 30.

  40. van Rossum IA, Vos SJB, Burns L, Knol DL, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Litalien G, van der Flier WM, Teunissen CE, Blennow K, Barkhof F, Rueckert D, Wolz R, Verhey F, Visser PJ. Injury markers predict time to dementia in subjects with MCI and amyloid pathology. Neurology. 2012; 79(17):1809-16. Epub 2012 Sep 26.

  41. Vellas B, Hampel H, Rougé-Bugat ME, Grundman M, Andrieu S, Abu-Shakra S, Bateman R, Berman R, Black R, Carrillo M, Donohue M, Mintun M, Morris J, Petersen R, Thomas RG, Suhy J, Schneider L, Seely L, Tariot P, Touchon J, Weiner M, Sampaio C, Aisen P, Task Force Participants. Alzheimers disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. J Nutr Health Aging. 2012; 16(4):339-45.

  42. Vos S, van Rossum I, Burns L, Knol D, Scheltens P, Soininen H, Wahlund LO, Hampel H, Tsolaki M, Minthon L, Handels R, L’Italien G, van der Flier W, Aalten P, Teunissen C, Barkhof F, Blennow K, Wolz R, Rueckert D, Verhey F, Visser PJ. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol Aging. 2012; 33(10):2272-81. Epub 2012 Jan 20.

  43. Wagner M, Wolf S, Reischies FM, Daerr M, Wolfsgruber S, Jessen F, Popp J, Maier W, Hüll M, Frölich L, Hampel H, Perneczky R, Peters O, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology. 2012; 78(6):379-86. Epub 2012 Jan 11.

  44. Wei X, Roettger Y, Tan B, He Y, Dodel R, Hampel H, Wei G, Haney J, Gu H, Johnstone BH, Farlow MR, Du Y. Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity. J Biol Chem. 2012; 287(16):12858-66. Epub 2012 Feb 23.

  45. Wetterling T, Schneider B. Medikamentenmissbrauch bei älteren psychiatrischen Patienten. [Prescription drug abuse in elderly psychiatric patients]. Psychiatr Prax. 2012; 39(6):275-9.

  46. Yakushev I, Müller MJ, Buchholz HG, Lang U, Rossmann H, Hampel H, Schreckenberger M, Fellgiebel A. Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer’s disease. Curr Alzheimer Res. 2012; 9(2):241-7. Epub 2011 Oct 26.

 

Reviews

  1. del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, Molinuevo JL, Parnetti L, Perret-Liaudet A, Sáez-Valero J, Saka E, Urbani A, Vanmechelen E, Verbeek M, Visser PJ, Teunissen C. Recommendations to standardize preanalytical confounding factors in Alzheimers and Parkinsons disease cerebrospinal fluid biomarkers: an update. Biomark Med. 2012; 6(4):419-30.

  2. Fußer F, Karakaya T, Prvulovic D, Hampel H. Improving the accuracy of dementia diagnosis with functional imaging. Dementia Europe. 2012; 4:4-6.

  3. Gerlach M, Maetzler W, Broich K, Hampel H, Rems L, Reum T, Riederer P, Stöffler A, Streffer J, Berg D. Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics. J Neural Transm. 2012; 119(1):39-52. Epub 2011 Jul 14.

  4. Hampel H. Current insights into the pathophysiology of Alzheimers disease: selecting targets for early therapeutic intervention. Int Psychogeriatr. 2012; 24(Suppl 1):S10-7.

  5. Hampel H, Lista S, Khachaturian ZS. Development of biomarkers to chart all Alzheimers disease stages: the royal road to cutting the therapeutic Gordian Knot. Alzheimers Dement. 2012; 8(4):312-36.

  6. Karakaya T, Fußer F, Prvulovic D, Hampel H. Treatment options for tauopathies. Curr Treat Option Ne. 2012; 14(2):126-36. Epub 2012 Feb 4.

  7. Karakaya T, Prvulovic D, Fußer F, Hampel H. Sind Biomarker des Morbus Alzheimer schon praxisrelevant? Neuro aktuell. 2012; 26(5):30-31.

  8. Knöchel C, Oertel-Knöchel V, O’Dwyer L, Prvulovic D, Alves G, Kollmann B, Hampel H. Cognitive and behavioural effects of physical exercise in psychiatric patients. Prog Neurobiol. 2012; 96(1):46-68. Epub 2011 Nov 24.

  9. Schneider B. Behavioural therapy of suicidality. Eur Arch Psychiatry Clin Neurosci. 2012; 262 Suppl 2:S123-8.

 

Bücher | Books

  1. Freitag CM, Barocka A, Fehr C, Grube M, Hampel H (Hg.). Depressive Störungen über die Lebensspanne. Ätiologie, Diagnostik und Therapie. Kohlhammer, Stuttgart, 2012.

  2. Hampel H, Carrillo MC, Ebert D, Ebmeier KP, Gattaz WF, Kaschke WP (Hg.). Alzheimer’s Disease – Modernizing Concept, Biological Diagnosis and Therapy. Advances in Biological Psychiatry, Vol. 28. Karger Verlag, Basel, 2012.

 

Buchbeiträge | Book Chapters

  1. Ademmer K. Somatoforme Störungen. In: Kompendium der Psychotherapie (Hg.: Kircher T). Berlin, Springer, 2012, 313-32.

  2. Hampel H, Prvulovic D. Leuchtturm-Projekte in der Demenzforschung. In: Personalakquise im Krankenhaus. Ärzte gewinnen, binden, entwickeln (Hg.: Kirchner H, Schroeter M, Flesch M). Springer, Berlin, Heidelberg, 2012, 106-11.

  3. Karakaya T, Pantel J. Psychopharmakaintervention bei primär affektiven Störungen. In: Angewandte Gerontologie: Interventionen für ein gutes Altern in 100 Schlüsselbegriffen (Hg.: Wahl H-W, Tesch-Römer C, Ziegelmann J). Kohlhammer, Stuttgart, 2012, 342-8.

  4. Mehl S, Seipelt M, Tennie C, Ademmer K. Kognitive Beeinträchtigung im Alter. In: Kompendium der Psychotherapie (Hg.: Kircher T). Berlin, Springer, 2012, 371-94.

  5. Schneider B, Weber B, Hampel H. Depression im Alter. In: Depressive Störungen über die Lebensspanne (Hg.: Freitag CM, Barocka A, Fehr C, Grube M, Hampel H), Kohlhammer, Stuttgart, 2012, 65-78.

 

geändert am 27. Januar 2014  E-Mail: Kontaktpsychiatrie@kgu.de

|

| Zur Navigationshilfe
empty

Seitenabschlussleiste


Druckversion: 27. Januar 2014, 15:50
http://www.uni-frankfurt.de/fb/fb16/fachklinik/psychiatrie/publikationen/pub_2012.html